Antiplatelet therapy after pancreaticoduodenectomy with portal vein resection may be the optimal anticoagulatant. (September 2018) - Sastry, A.; Passeri, M.; Lyman, W.; Murphy, K.; Baker, E.; Martinie, J.; Iannitti, D.; Vrochides, D.